Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 3
1996 6
1997 7
1998 11
1999 12
2000 19
2001 5
2002 9
2003 10
2004 12
2005 12
2006 12
2007 14
2008 8
2009 22
2010 17
2011 17
2012 26
2013 31
2014 26
2015 18
2016 18
2017 11
2018 8
2019 7
2020 8
2021 10
2022 3
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

338 results

Results by year

Filters applied: . Clear all
Page 1
Intermittent androgen deprivation therapy in patients with prostate cancer: Connecting the dots.
Abrahamsson PA. Abrahamsson PA. Asian J Urol. 2017 Oct;4(4):208-222. doi: 10.1016/j.ajur.2017.04.001. Epub 2017 Apr 22. Asian J Urol. 2017. PMID: 29387553 Free PMC article. Review.
Intermittent androgen deprivation therapy (IADT) is now being increasingly opted by the treating physicians and patients with prostate cancer. ...IADT may also delay the progression to castration-resistant prostate cancer. However, the use of IADT in t …
Intermittent androgen deprivation therapy (IADT) is now being increasingly opted by the treating physicians and patients with …
Comparison of Intermittent and Continuous Androgen Deprivation Therapy in Prostate Cancer Patients: An Up-to-Date Meta-analysis for Urologists and Medical Providers.
Becker B, Stroever S, Reddy A, de Riese WTW. Becker B, et al. Urol Pract. 2023 Sep;10(5):424-434. doi: 10.1097/UPJ.0000000000000424. Epub 2023 Jul 28. Urol Pract. 2023. PMID: 37505912 Review.
RESULTS: A total of 12 randomized clinical trials met all inclusion criteria for final analysis. There was no statistically significant difference in prostate cancer-specific mortality between intermittent androgen deprivation therapy and continuous androgen …
RESULTS: A total of 12 randomized clinical trials met all inclusion criteria for final analysis. There was no statistically significant diff …
Intermittent androgen deprivation therapy in advanced prostate cancer.
Alva A, Hussain M. Alva A, et al. Curr Treat Options Oncol. 2014 Mar;15(1):127-36. doi: 10.1007/s11864-013-0272-2. Curr Treat Options Oncol. 2014. PMID: 24395278 Review.
Prostate cancer is an androgen driven cancer. Androgen deprivation therapy (ADT) has been the standard first line therapy for metastatic prostate cancer. ...The lower incidence of severe adverse events including cord compression in advanced prostate cancer wi …
Prostate cancer is an androgen driven cancer. Androgen deprivation therapy (ADT) has been the standard first line therapy for metasta …
Intermittent vs Continuous Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-analysis.
Magnan S, Zarychanski R, Pilote L, Bernier L, Shemilt M, Vigneault E, Fradet V, Turgeon AF. Magnan S, et al. JAMA Oncol. 2015 Dec;1(9):1261-9. doi: 10.1001/jamaoncol.2015.2895. JAMA Oncol. 2015. PMID: 26378418 Review.
Intermittent androgen deprivation has been studied as an alternative. ...Some quality-of-life criteria seemed improved with intermittent therapy. Intermittent androgen deprivation can be considered as an alternative option in patients with recurrent or …
Intermittent androgen deprivation has been studied as an alternative. ...Some quality-of-life criteria seemed improved with in …
Intermittent androgen suppression for prostate cancer.
Buchan NC, Goldenberg SL. Buchan NC, et al. Nat Rev Urol. 2010 Oct;7(10):552-60. doi: 10.1038/nrurol.2010.141. Epub 2010 Sep 14. Nat Rev Urol. 2010. PMID: 20842189 Review.
Although androgen deprivation therapy (ADT) has been a cornerstone of the management of prostate cancer for more than 50 years, controversy remains regarding its optimum application. Intermittent androgen suppression (IAS) has been researched since the mid-19 …
Although androgen deprivation therapy (ADT) has been a cornerstone of the management of prostate cancer for more than 50 years, contr …
Intermittent versus continuous androgen deprivation therapy in advanced prostate cancer.
Klotz L. Klotz L. Curr Urol Rep. 2013 Jun;14(3):159-67. doi: 10.1007/s11934-013-0325-x. Curr Urol Rep. 2013. PMID: 23700095 Review.
Intermittent androgen deprivation is increasingly employed as an alternative to continuous life long androgen deprivation therapy for men with advanced or recurrent prostate cancer. ...The recent results of randomized clinical trials now establish that int …
Intermittent androgen deprivation is increasingly employed as an alternative to continuous life long androgen deprivation ther …
Intermittent androgen deprivation therapy for prostate cancer: translating randomized controlled trials into clinical practice.
Dason S, Allard CB, Wang JG, Hoogenes J, Shayegan B. Dason S, et al. Can J Urol. 2014 Apr;21(2 Supp 1):28-36. Can J Urol. 2014. PMID: 24775721 Free article. Review.
INTRODUCTION: Intermittent androgen deprivation therapy (IADT) for prostate cancer involves cycles of androgen deprivation therapy (ADT) with a period between cycles where testosterone is allowed to rise above castrate levels. ...CONCLUSIONS: IADT remains a t …
INTRODUCTION: Intermittent androgen deprivation therapy (IADT) for prostate cancer involves cycles of androgen deprivat …
Intermittent androgen deprivation therapy for prostate cancer.
Rashid MH, Chaudhary UB. Rashid MH, et al. Oncologist. 2004;9(3):295-301. doi: 10.1634/theoncologist.9-3-295. Oncologist. 2004. PMID: 15169984 Free article. Review.
The natural history of prostate cancer while on such therapy is the attainment of an incurable androgen-independent state. ...Intermittent androgen deprivation offers clinicians a prospect to improve quality of life in patients with prostate cancer by …
The natural history of prostate cancer while on such therapy is the attainment of an incurable androgen-independent state. ...Inte …
Intermittent androgen-deprivation therapy in prostate cancer: a critical review focused on phase 3 trials.
Sciarra A, Abrahamsson PA, Brausi M, Galsky M, Mottet N, Sartor O, Tammela TL, Calais da Silva F. Sciarra A, et al. Eur Urol. 2013 Nov;64(5):722-30. doi: 10.1016/j.eururo.2013.04.020. Epub 2013 Apr 19. Eur Urol. 2013. PMID: 23628492 Review.
CONTEXT: Intermittent androgen deprivation (IAD) in prostate cancer (PCa) patients has been proposed to delay development of castration resistance and to reduce the side effects and costs of androgen deprivation therapy (ADT). ...EVIDENCE ACQUISITION: We sear …
CONTEXT: Intermittent androgen deprivation (IAD) in prostate cancer (PCa) patients has been proposed to delay developme …
Intermittent androgen suppression for prostate cancer: rationale and clinical experience.
Gleave M, Bruchovsky N, Goldenberg SL, Rennie P. Gleave M, et al. Eur Urol. 1998;34 Suppl 3:37-41. doi: 10.1159/000052297. Eur Urol. 1998. PMID: 9854195 Review.
The rationale behind intermittent androgen suppression (IAS) is based on: (1) observations that androgen ablation is palliative, not curative, in most patients with prostate cancer, and that quality of life must be considered; (2) the assumption that immediat …
The rationale behind intermittent androgen suppression (IAS) is based on: (1) observations that androgen ablation is palliativ …
338 results